Fatty acids, triglycerides, and glucose metabolism: Recent insights from knockout mice

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 5, Issue 4, 2002, Pages 359-363

  Chen, Hubert C ^a,b,c   Farese Jr , Robert V ^a,b,c  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Diabetes; Fatty acid; Glucose metabolism; Insulin resistance; Knockout mice; Lipotoxicity; Triglyceride; Triglyceride synthesis

Indexed keywords

ACYL COENZYME A; CARRIER PROTEIN; CD36 ANTIGEN; DIACYLGLYCEROL ACYLTRANSFERASE; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

CATALYSIS; DIABETES MELLITUS; ENZYME ACTIVITY; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HYDROLYSIS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID METABOLISM; MOUSE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; REVIEW; ANIMAL; GENETICS; METABOLIC DISORDER; METABOLISM; MOUSE MUTANT;

ANIMALS; FATTY ACIDS; GLUCOSE; METABOLIC DISEASES; MICE; MICE, KNOCKOUT; TRIGLYCERIDES;

EID: 0036633390     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200207000-00002     Document Type: Review

References (45)

1. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14:263-283.
2. Boden G. Obesity, free fatty acids, and insulin resistance. Curr Opin Endocrinol Diabetes 2001; 8:235-239.
3. Roden M, Price TB, Perseghin G, et al. Mechanisms of free fatty acid-induced insulin resistance in humans. J Clin Invest 1996; 97:2859-2865.
4. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106:171-176.
5. Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C q and alterations in the insulin signaling cascade. Diabetes 1999; 48:1270-1274.
6. Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkb. Science 2001; 293:1673-1677. Implicates the involvement of the Ikkb inflammatory signaling pathway in insulin resistance.
7. Kim JK, Kim Y-J, Fillmore JJ, et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 2001; 108:437-446. Implicates Ikkb signaling in mediating insulin resistance caused by lipid infusion.
8. Farese RV. Insulin-sensitive phospholipid signaling systems and glucose transport: update II. Exp Biol Med 2001; 226:283-295.
9. Weinstock PH, Bisgaier CL, Aalto-Setälä K, et al. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes. J Clin Invest 1995; 96:2555-2568.
10. Coleman T, Seip RL, Gimble JM, et al. COOH-terminal disruption of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J Biol Chem 1995; 270:12518-12525.
11. Merkel M, Weinstock PH, Chajek-Shaul T, et al. Lipoprotein lipase expression exclusively in liver: a model for metabolism in the neonatal period and during cachexia. J Clin Invest 1998; 102:893-901.
12. Marshall BA, Tordjman K, Host HH, et al. Relative hypoglycemic and hyperinsulinemia in mice with heterozygous lipoprotein lipase (LPL) deficiency: islet LPL regulates insulin secretion. J Biol Chem 1999; 274:27426-27432.
13. Jensen DR, Schlaepfer IR, Morin CL, et al. Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase. Am J Physiol 1997; 273:R683-R689.
14. Levak-Frank S, Radner H, Walsh A, et al. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J Clin Invest 1995; 96:976-986.
15. Ferreira LDMC-B, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes 2001; 50:1064-1068. Analyzes glucose metabolism in mice overexpressing LPL in skeletal muscle.
16. Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 2001; 98:7522-7527. Analyzes glucose metabolism in mice overexpressing LPL in different tissues.
17. Voshol PJ, Jong MC, Dahlmans VEH, et al. In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake. Diabetes 2001; 50:2585-2590. Analyzes glucose metabolism in mice overexpressing LPL in skeletal muscle.
18. Abumrad NA, El-Maghrabi MR, Amri E-Z, et al. Cloning of rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. J Biol Chem 1993; 268:17665-17668.
19. Febbraio M, Abumrad NA, Hajjar DP, et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 1999; 274:19055-19062.
20. Ibrahim A, Bonen A, Blinn WD, et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 1999; 274:26761-26766.
21. Lewin TM, Kim J-H, Granger DA, et al. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently. J Biol Chem 2001; 276:24674-24679.
22. Farese Jr RV, Cases S, Smith SJ. Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase. Curr Opin Lipidol 2000; 11:229-234.
23. Cases S, Smith SJ, Zheng Y-W, et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A 1998; 95:13018-13023.
24. Cases S, Stone SJ, Zhou P, et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001; 276:38870-38876.
25. Smith SJ, Cases S, Jensen DR, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT. Nat Genet 2000; 25:87-90.
26. Chen HC, Smith SJ, Ladha Z, et al. Increasing insulin and leptin sensitivity in mice lacking acyl CoA: diacylglycerol acyltransferase I. J Clin Invest 2002; in press.
27. Boden G, Lebed B, Schatz M, et al. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 2001; 50:1612-1617. Studies in healthy human volunteers correlating changes in intramyocellular fat with insulin resistance.
28. Murray I, Havel PJ, Sniderman AD, Cianflone K. Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000; 141:1041-1049.
29. Murray I, Sniderman AD, Havel PJ, Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 1999; 274:36219-36225.
30. Servetnick DA, Brasaemle DL, Gruia-Gray J, et al. Perilipins are associated with cholesteryl ester droplets in steroidogenic adrenal cortical and Leydig cells. J Biol Chem 1995; 270:16970-16973.
31. Brasaemle DL, Rubin B, Harten IA, et al. Perilipin A increases triacylglycerol storage by decreasing the rate of triacylglycerol hydrolysis. J Biol Chem 2000; 275:38486-38493.
32. db/db mice. Nat Genet 2000; 26:474-479.
33. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci U S A 2001; 98:6494-6499. Describes the phenotype of perilipin-deficient mice with respect to energy and glucose metabolism.
34. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7:941-946. Identifies adiponectin/Acrp30 as an adipocyte-derived protein with potent insulin-sensitizing effects.
35. Kubota N, Terauchi Y, Miki H, et al. PPARg mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4:597-609.
36. Osuga J-I, Ishibashi S, Oka T, et al. Targeting disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci U S A 2000; 97:787-792.
37. Roduit R, Masiello P, Wang SP, et al. A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 2001; 50:1970-1975. Describes the phenotype of hormone-sensitive lipase-deficient mice with respect to glucose metabolism.
38. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106:473-481.
39. Shimomura I, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401:73-76.
40. Chinookoswong N, Wang J-L, Shi Z-Q. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes 1999; 48:1487-1492.
41. Ogawa Y, Masuzaki H, Hosoda K, et al. Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin. Diabetes 1999; 48:1822-1829.
42. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
43. Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7:947-953. Identifies adiponectin/Acrp30 as an adipocyte-derived protein with potent insulin-sensitizing effects.
44. Wallenius V, Wallenius K, Ahrén B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002; 8:75-79.
45. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312. Identifies resistin as a potential adipocyte-derived protein that modulates insulin resistance.